Interstitial pneumonia combined with nocardia cyriacigeorgica infection: A case report

• Published in: World journal of clinical cases 2023-11, Vol.11 (32), p.7920-7925
• Main Authors: Qi, Dao-Da, Zhuang, Yi, Chen, Yang, Guo, Jing-Jing, Zhang, Ze, Gu, Yan
• Format: Article
• Language: English
• ISSN: 2307-8960; 2307-8960
• DOI: 10.12998/wjcc.v11.i32.7920

Nocardia infection is a relatively uncommon disease, with no reports among patients with interstitial pneumonia. Due to its atypical clinical symptoms and chest computed tomography (CT) findings and the frequent yielding of negative results by conventional cultures, it poses challenges for timely diagnosis and treatment. A 63-year-old female patient presented to our hospital in July 2022 with a 3-mo history of intermittent cough and poor appetite, accompanied by a 2-wk long duration of headaches. She had a previous medical history of interstitial pneumonia and was on oral prednisone and cyclosporine. Chest CT revealed the presence of newly developed round nodules. The diagnosis of infection was confirmed through metagenomic next-generation sequencing (mNGS) performed on bronchoalveolar lavage fluid. Targeted anti-infection therapy was initiated, resulting in symptom improvement and radiological resolution, further validating the mNGS results. Nocardia cyriacigeorgica infection is a clinically rare condition that is primarily observed in immunocompromised patients. Its clinical and radiological manifestations lack specificity, but mNGS can aid in rapidly obtaining pathogenic information. Early initiation of targeted antimicrobial therapy based on mNGS results can improve patient prognosis.